NASDAQ

Vistagen Therapeutics, Inc. (VTGN)

♥ 741 Thanks from members

Live price chart, market sentiment, and community perspectives for Vistagen Therapeutics, Inc. (NASDAQ: VTGN).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Health CareIndustry: BiotechnologyFounder: H. Isaac RabinovitzFounder: J. Jay McMahonLeadership: Shawn Singh (Chief Executive Officer)Leadership: Mark Smith (Chief Financial Officer)Holder: Vanguard Group Inc.Holder: BlackRock Inc.Holder: Renaissance Technologies LLCFelypressinPH94BPH10#VTGN#Vistagen Therapeutics#biotech stock#neuroscience therapeutics#PH94B clinical trials